Laeeq, T.; Ahmed, M.; Sattar, H.; Zeeshan, M.H.; Ali, M.B.
Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention. Cancers 2024, 16, 1325.
https://doi.org/10.3390/cancers16071325
AMA Style
Laeeq T, Ahmed M, Sattar H, Zeeshan MH, Ali MB.
Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention. Cancers. 2024; 16(7):1325.
https://doi.org/10.3390/cancers16071325
Chicago/Turabian Style
Laeeq, Tooba, Maheen Ahmed, Hina Sattar, Muhammad Hamayl Zeeshan, and Meher Binte Ali.
2024. "Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention" Cancers 16, no. 7: 1325.
https://doi.org/10.3390/cancers16071325
APA Style
Laeeq, T., Ahmed, M., Sattar, H., Zeeshan, M. H., & Ali, M. B.
(2024). Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention. Cancers, 16(7), 1325.
https://doi.org/10.3390/cancers16071325